UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
JUBILANT DRAXIMAGE INC.,
Plaintiff,
v. Civil Action No. 19-1494 (RDM) UNITED STATES INTERNATIONAL TRADE COMMISSION,
Defendant.
MEMORANDUM OPINION AND ORDER
Plaintiff Jubilant DraxImage Inc. (“JDI”) manufactures a Rubidium Elution System
(“RUBY”), one of only two medical devices used for Cardiac Positron Emission Tomography, a
non-invasive imaging procedure designed to evaluate patients for coronary artery disease. JDI’s
principal—indeed only—competitor in this specialized field is Bracco Diagnostics Inc.
(“Bracco”), a company manufacturing a similar device. JDI is currently in proceedings before
the United States International Trade Commission (“the Commission”) addressing whether JDI’s
RUBY technology infringes on a series of Bracco’s patents. In the course of those proceedings,
the Commission ordered JDI publicly to disclose portions of its briefs, all of which were filed
under seal. JDI objects to making public those portions of its briefs that cite or reference
Bracco’s patent claims. The reason? Revealing the specific Bracco claim elements at issue
would, according to JDI, allow Bracco to modify or remove the very claim elements that make
JDI’s products non-infringing. In other words, Bracco could use JDI’s references to particular
portions of Bracco’s lengthy patent claims, which are public, to infer the manner in which JDI
has attempted to engineer around Bracco’s patents, which is not public. JDI seeks a preliminary
1 injunction to prohibit the Commission from enforcing its disclosure order. As explained below,
JDI has demonstrated that it is entitled to preliminary relief. The Court will therefore GRANT
the motion for a preliminary injunction.
I. BACKGROUND
JDI is a radiopharmaceutical company based in Kirkland, Canada. Dkt. 1 at 3 (Compl.
¶ 7). Among other things, JDI markets a medical device named RUBY, an elution system that
generates Rubidium-82 Chloride, a chemical used for Cardiac Positron Emission Tomography, a
non-invasive imaging procedure used to evaluate regional myocardial perfusion in adult patients
with suspected or existing coronary artery disease. Id. at 4 (Compl. ¶ 11). The Food and Drug
Administration (“FDA”) first approved RUBY in 2016. Id. (Compl. ¶ 12). As soon as the FDA
approved JDI’s device, Bracco submitted a FOIA request to the FDA and obtained a RUBY
product manual from the agency. Id. (Compl. ¶ 13). Bracco was able to claim priority to earlier-
filed patent applications and, between September and November 2017, Bracco used information
in the product manual to seek and to obtain three continuation patents crafted to claim the
technology found in the RUBY product. Id. at 4–5 (Compl. ¶ 13). As soon as those patents
issued, Bracco filed a complaint with the Commission, alleging violations of Section 337 of the
Tariff Act of 1930, 19 U.S.C. § 1337. Id. at 5 (Compl. ¶ 14). The Commission instituted the
current investigation in May 2018. Id.
In response to Bracco’s complaint with the Commission, JDI created two new versions of
RUBY “specifically designed to avoid infringement of Bracco’s three patents”—Versions 3.1
and 4. Id. (Compl. ¶ 17). In proceedings before the Commission, JDI attempted to show that
these new versions did not infringe Bracco’s existing patents. JDI filed a motion for summary
determination (“MSD”)—the equivalent of a summary judgment motion—which compared the
2 technology behind Versions 3.1 and 4 against Bracco’s patent claims. Id. at 6 (Compl. ¶ 21); see
also Dkt. 4-5 at 15–56 (Ex. 1 to Confidential Ex. E). To show that the new versions did not
infringe Bracco’s patents, JDI quoted specific portions of—and highlighted key terms in—
Bracco’s lengthy patent claims. Dkt. 4-5 at 24–27. “Because the emphasized claim limitations
identif[ied] the specific features of the RUBY product that were redesigned,” JDI feared that, if
made aware of the precise claim elements that JDI had designed around, Bracco would file yet
another set of continuation patents in an effort to exclude the new designs utilized in Versions
3.1 and 4. Dkt. 1 at 6–7 (Compl. ¶¶ 23–24). JDI, accordingly, treated all references to Bracco’s
claim elements as “confidential business information” pursuant to Commission regulations and
“redacted the portions of its [briefs] discussing, quoting, and emphasizing these limitations of
Bracco’s patent claims in the public version of its brief.” Dkt. 1 at 6 (Compl. ¶ 23). JDI did this
in four portions of its brief: the background sections for Versions 3.1 and 4, which list the
particular claim elements at issue, and in the merits sections for Versions 3.1 and 4, which argue
that the new designs do not infringe the identified claim elements.
Commission staff attorneys objected to a number of JDI’s redactions and filed a motion
to declassify portions of JDI’s brief. See Dkt. 4-1 (Confidential Ex. A). Specifically, the
Commission staff argued that “passages quoting from [Bracco’s] patents or descriptions of the
scope of patents and claims do not fall within the Commission’s definition of confidential
business information” and that, “unless the sentence explicitly describes the specific aspects of
the RUBY Version 3.1 and Version 4 systems, any quotation from or discussion of the asserted
[Bracco] patents should not be redacted.” Id. at 4–5. JDI opposed the motion, arguing that
“[a]ny patent attorney reading a brief seeking a determination of noninfringement that provides a
background overview of specific claim limitations would readily recognize that those claim
3 limitations form the basis for why the confidential products do not infringe” and that, “for
example,” one of Bracco’s limitations “concerns a binary design option.” Dkt. 4-2 at 11
(Confidential Ex. B). Reviewing a proposed, redacted brief provided by Commission staff,
moreover, JDI compared redactions approved by the Commission staff to those rejected and
argued that “there is no real difference between the redacted passages reproduced below that the
Staff seeks to reclassify. . . and those it has approved.” Id. at 12–13.
On March 21, 2019, a Commission Administrative Law Judge (“ALJ”) issued Order No.
31, “Initial Determination Granting-in-Part Commission Investigative Staff’s Motion to
Declassify Portions of Respondents’ Motion for Summary Determination.” Dkt. 4-3
(Confidential Ex. C). The Order explained that “confidentiality determinations . . . are governed
by the definition given in 19 C.F.R. § 201.6(a).” Id. at 4. That definition, according to the ALJ,
mandates a “two-part test.” Id. First, the ALJ “asks whether the contested information ‘concerns
or relates to the trade secrets, processes, operations, style of works, or apparatus, or to the
production, sales, shipments, purchases, transfers, identification of customers, inventories, or
amount or source of any income, profits, losses or expenditures of any person, firm, partnership,
corporation, or other organization, or other information of commercial value.’” Id. at 3 (citation
omitted) (quoting 19 C.F.R. § 201.6(a)). Second, the ALJ determines whether “the disclosure of
such information [would] be likely to have the effect of either (1) ‘impairing the Commission’s
ability to obtain such information as is necessary to perform its statutory functions,’ or (2)
‘causing substantial harm to the competitive position of the person, firm, partnership,
corporation, or other organization from which the information was obtained.’” Id. at 3–4
(alteration in original) (citation omitted) (quoting 19 C.F.R. § 201.6(a)).
4 The ALJ acknowledged JDI’s argument that, “by identifying specific claim limitations
that are not practiced by [JDI’s] revised products, a reader may deduce the operation of those
products.” Id. at 4. With respect to Version 3.1, for example, the ALJ noted JDI’s argument that
the relevant claim element concerned “a binary design decision” and “that language in its brief
stating that it does not practice the [specific] limitation necessarily reveals . . . the [RUBY]
elements in question . . . and that is competitive information not available to the public.” Id. at
4–5. Applying the two-part test, the ALJ “agree[d] that declassification of those redactions [i.e.,
those that revealed a “binary design decision”] from the public version of the [JDI] MSD would
reveal a confidential design feature of [JDI’s] product,” and, accordingly, rejected the
Commission staff’s motion with respect to those redactions. Id. at 5. Turning to the Version 4
patents, however, the ALJ determined that “it is not true, as a factual matter, that a reader can
deduce the configuration of [JDI’s] product from [those specific Bracco claim] statements”
because “[m]ultiple possibilities exist . . . that avoid[] the limitation in question.” Id. at 5–6. The
ALJ, accordingly, concluded that specific references to Bracco’s patents related to RUBY
Version 4 “do not constitute [JDI’s] confidential business information” and ordered JDI “to file a
replacement public version of its motion for summary determination with the improper
redactions removed.” Id. at 6.
JDI appealed to the Commission. Dkt. 4-4 (Confidential Ex. D). Arguing that the ALJ’s
focus on whether the specific design choices “involve[d] a binary, either-one-or-the-other
choice . . . misses the point,” JDI stressed that “early identification of the emphasized claim
limitations will reveal to Bracco the specific limitations that [JDI’s] Version 4 products omit,
which would allow Bracco to file new applications containing claims that simply omit the
designed-around limitations.” Id. at 15. On May 6, 2019, the Commission issued a Notice of
5 Commission Decision to Review in Part an Initial Determination Granting-in-Part a Motion to
Declassify (“Notice”). Dkt. 1-1 (Compl. Ex. A). In a single sentence, the Commission affirmed
the ALJ’s Order No. 31.1 Id. at 3. The Commission also attached a version of JDI’s brief,
edited by Commission staff, showing which redactions the Commission approved and which
redactions JDI would have to forgo. See id. at 2; see also Dkt. 4-5 at 11–56 (Ex. 1 to
Confidential Ex. E). The Commission stayed its order for 21 days to allow JDI to seek judicial
review of its disclosure order. Dkt. 1-1 at 3 (Compl. Ex. A). The Commission later extended
that stay until July 12, 2019. June 21, 2019 Hrg. Tr. (Rough at 20:17–19).
JDI filed the instant suit on May 22, 2019, seeking relief under the Administrative
Procedure Act (“APA”), 5 U.S.C. § 701 et seq. and a writ of mandamus, 28 U.S.C. § 1361.
Among other things, JDI alleges that the Notice is “arbitrary, capricious, and contrary to law,”
Dkt. 1 at 11 (Compl. ¶ 44), and that the Commission “owes a non-discretionary duty not to
disclose information properly designated as confidential under Commission rules,” id. at 12
(Compl. ¶ 56). JDI filed a motion for a preliminary injunction that same day, Dkt. 3, as well as a
motion to seal portions of the administrative record, Dkt. 4.2 After setting a schedule with the
1 The Commission also ordered that JDI make one additional redaction. Dkt. 1-1 at 3 (Compl. Ex. A). That redaction is not at issue here. See Dkt. 1 at 8 (Compl. ¶ 33). 2 The Commission opposes the motion to seal portions of the administrative record to the extent that sealing goes beyond “information considered [confidential business information (“CBI”)] by the Commission and not in dispute in this case.” See Dkt. 12 at 12. The dispute regarding the motion to seal, accordingly, “simply parallels the merits” of the parties’ disclosure/non- disclosure arguments. See June 21, 2019 Hrg. Tr. (Rough at 31:17–18). Because the Court grants the preliminary injunction on APA grounds without deciding whether the underlying information can be properly withheld, the Court will preliminarily GRANT the motion to seal for the period that the preliminary injunction remains in place in order to preserve the status quo. Should the Court subsequently dissolve the injunction, the Commission is welcome to renew its request that JDI file unredacted versions of the sealed exhibits on the public docket. 6 parties’ consent, the Court held oral argument on June 21, 2019, and those motions are now ripe
for decision.
II. ANALYSIS
“A preliminary injunction is an extraordinary remedy never awarded as of right,” Winter
v. Nat. Res. Def. Council, Inc., 555 U.S. 7, 24 (2008), but “only when the party seeking the relief,
by a clear showing, carries the burden of persuasion,” Cobell v. Norton, 391 F.3d 251, 258 (D.C.
Cir. 2004). To secure a preliminary injunction, a plaintiff “must establish [1] that he is likely to
succeed on the merits, [2] that he is likely to suffer irreparable harm in the absence of
preliminary relief, [3] that the balance of equities tips in his favor, and [4] that an injunction is in
the public interest.” Winter, 555 U.S. at 20. “The last two factors ‘merge when the Government
is the opposing party.’” Guedes v. Bureau of Alcohol, Tobacco, Firearms & Explosives, 920
F.3d 1, 10 (D.C. Cir. 2019) (quoting Nken v. Holder, 556 U.S. 418, 435 (2009)).
Before the Supreme Court’s decision in Winter, courts in this circuit applied a “sliding-
scale” approach to the preliminary injunction analysis under which “a strong showing on one
factor could make up for a weaker showing on another.” Sherley v. Sebelius, 644 F.3d 388, 392
(D.C. Cir. 2011). Since Winter, the D.C. Circuit has hinted on several occasions that “a
likelihood of success is an independent, free-standing requirement for a preliminary injunction,”
id. at 393 (quoting Davis v. Pension Benefit Guar. Corp., 571 F.3d 1288, 1296 (D.C. Cir. 2009)
(Kavanaugh, J., concurring)), but it has repeatedly declined to decide that issue, see Am. Meat
Inst. v. U.S. Dep’t of Agric., 746 F.3d 1065, 1074 (D.C. Cir. 2014), reinstated in relevant part by
760 F.3d 18 (D.C. Cir. 2014) (en banc); see also League of Women Voters of United States v.
Newby, 838 F.3d 1, 7 (D.C. Cir. 2016); Sherley, 644 F.3d at 393 (reading “Winter at least to
suggest if not to hold ‘that a likelihood of success is an independent, free-standing requirement
7 for a preliminary injunction,’” but declining to decide the issue (quoting Davis, 571 F.3d at
1296)).
Here, because all four factors weigh in favor of granting a preliminary injunction, JDI is
entitled to preliminary relief regardless of whether the sliding-scale approach applies.
A. Likelihood of Success on the Merits
The APA directs courts to “hold unlawful and set aside agency action, findings, and
conclusions found to be . . . arbitrary, capricious, an abuse of discretion, or otherwise not in
accordance with law.” 5 U.S.C. § 706(2)(A). JDI contends that it is likely to succeed on the
merits of its APA challenge because the Commission’s order was both “contrary to law and
arbitrary and capricious.” Dkt. 3-1 at 14. In support, JDI raises a host of APA challenges to the
Commission’s choice to redact claim elements relating to the “binary” design choices of Version
3.1 but not elements concerning the “non-binary” possibilities of Version 4.
JDI first argues that the Commission’s “binary/non-binary” distinction is contrary to law
because it does not appear in the Commission’s regulations. June 21, 2019 Hrg. Tr. (Rough at
24:10–15). Second, JDI contends that even if the binary/non-binary distinction was proper, the
Commission misapplied that distinction. JDI suggests, for example, that claim elements
emphasized for Version 4 should themselves be considered “binary” because “they are either in
the claims or they are not.” Dkt. 3-1 at 15. JDI also argues that the Commission erroneously
concluded that several design features were non-binary when, in fact, JDI had only “essentially
binary” design options. June 21, 2019 Hrg. Tr. (Rough at 28:13–17); see also Dkt. 13 at 11 n.7
(“[T]he available design choices related to Version 4 are ‘virtually’ binary.” (quoting Dkt. 4-4 at
12–13) (Confidential Ex. D)). Third, and most forcefully, JDI contends that the Commission
erred when it failed to recognize that, “if the redacted limitations are disclosed, Bracco can draft
8 new patent claims to cover JDI’s trade-secret designs simply by eliminating the language JDI has
identified from its existing claims.” Dkt. 3-1 at 15. This, according to JDI, was doubly-wrong
under the APA: the Commission both misconstrued its own regulations when defining
“substantial harm to [JDI’s] competitive position,” id. at 14–15 (citing 19 C.F.R. § 201.6(a)), and
“[f]ail[ed] to properly consider” JDI’s “principal argument,” an independent and distinct ground
for finding the order arbitrary and capricious, id. at 15.
Ultimately, JDI may prevail on none, or one, or several of these claims. The Court,
however, need not evaluate each and every one of JDI’s theories for present purposes. Mindful
that the Court must not “substitute its judgment for that of the agency,” Motor Vehicle Mfrs.
Ass’n v. State Farm Mut. Auto Ins. Co., 463 U.S. 29, 43 (1983), it is sufficient at this early stage
of the litigation to conclude that JDI is likely to succeed on another, more straightforward APA
theory: that the proposed redactions themselves lack a coherent basis. As JDI contends, the
Commission treated identical language as confidential business information in some parts of
JDI’s brief, while ordering disclosure of that same language elsewhere in the same brief. See
Dkt. 13 at 7; see also June 21, 2019 Hrg. Tr. (Rough at 18:17–19:1).
It is axiomatic that the APA requires “reasoned decisionmaking.” State Farm, 463 U.S.
at 52. That principle requires the Court to assess whether the agency considered “the relevant
factors and whether there was a clear error in judgment.” Id. at 31; see also Judulang v. Holder,
565 U.S. 42, 53 (2011). To be sure, “[t]he scope of review under the ‘arbitrary and capricious’
standard is narrow.” State Farm, 463 U.S. at 43. But “the process by which [an agency] reaches
[its] result must be logical and rational.” Allentown Mack Sales & Serv., Inc. v. NLRB, 522 U.S.
359, 374 (1998). In other words, although a “court is not to substitute its judgment for that of the
agency, neither may a court sanction agency action when the agency . . . fails to justify seeming
9 inconsistencies in its approach,” Purepac Pharm. Co. v. Thompson, 354 F.3d 877, 884 (D.C. Cir.
2004) (internal quotations omitted) (quoting Prof’l Pilots Fed’n v. FAA, 118 F.3d 758, 771 (D.C.
Cir. 1997)).
Looking at the proposed redactions in detail, the Court concludes that the Commission
fails this deferential standard. In a version of JDI’s brief reflecting the Commission’s decisions,
the Commission highlighted approved redactions in yellow and rejected redactions in red. But
on multiple occasions, the Commission reached inconsistent results as to identical or equivalent
language. On page 30 of JDI’s motion for summary determination, for example, JDI included a
table identifying specific claim elements that JDI designed around in Version 4. See Dkt. 4-5 at
49 (Confidential Ex. E). The Commission ordered JDI to disclose every claim element on this
page. Id. at 48–49 (highlighting elements in red). Yet, on the very next page, JDI begins a
section entitled “no literal infringement” with the sentence: “The Version 4 design has no . . . ”
and proceeds to quote one of the claim elements from the preceding page. Id. at 50. Notably,
the Commission concluded that that language was properly redacted. Id. (highlighting elements
in yellow). This appears to be more than a simple oversight. On page 32 of JDI’s brief, the
Commission approved redacting the sentence: “[T]he Version 4 design does not possess [a
specific Bracco claim element].” Id. at 51 (highlighting in yellow). Appended to that sentence is
a footnote, which reads: “[A different Bracco claim element] recites this same subject matter
using alternate language. It states that . . .” and then quotes from the separate claim element. Id.
The claim element “recit[ing] this same subject matter using alternate language” is then marked
as unredacted. Id. (highlighting in red). Other, similar inconsistences appear elsewhere.
Compare, e.g., Dkt. 4-5 at 51 (Confidential Ex. E) (“Version 4 . . . does not possess [claim
language A].”) (highlighted in yellow), with id. at 52 (“[Claim A] recites . . . [claim language
10 A] . . . Version 4 is the antithesis of the Assert Patent.”) (highlighted in red). In other words,
there are both inconsistencies between treatment of identical language in the background and the
analysis sections, and also inconsistent treatment of language within the analysis section.
Neither the Commission’s final order nor the ALJ’s decision explains the reason for these
discrepancies. At oral argument, counsel for the Commission argued that these examples are not
really inconsistencies at all because the ALJ redacted information where “the subject of [the]
sentence is the Version 4 design product,” but not where the brief merely “recites” a patent
claim—because “that’s clearly claim language that is public information.” June 21, 2019 Hrg.
Tr. (Rough at 48:10–20). There are several problems with that argument. As an initial matter,
neither the Court nor counsel may “supply a reasoned basis for [an] agency’s action that the
agency itself has not given,” Bowman Transp., Inc. v. Arkansas-Best Freight Sys., Inc., 419 U.S.
281, 285–86 (1974) (citing SEC v. Chenery Corp. (“Chenery II”), 332 U.S. 194, 196 (1947)),
and a distinction based on the “subject of [the] sentence,” June 21, 2019 Hrg. Tr. (Rough at
48:11–12), does not appear anywhere in the ALJ’s decision or the Commission’s order.
Nor, moreover, is that logic compatible with the ALJ’s actual reasoning. According to
the ALJ’s decision, which the Commission affirmed, the Bracco claim elements “do not
constitute [JDI’s] confidential business information” because “it is not true, as a factual matter,
that a reader can deduce the configuration of [JDI’s] product from [those specific Bracco claim]
statements;” rather, “[m]ultiple possibilities exist . . . that avoid[] the limitation in question.”
Dkt. 4-3 at 5–6 (Confidential Ex. C). In other words, revealing a non-binary Bracco claim
element does no competitive harm to JDI because Version 4 could be configured in any number
of other ways. But if that were true, it would make little sense for the ALJ to redact Bracco’s
claim elements even when “the subject of [the] sentence is the Version 4 design product.” Put
11 differently, if the ALJ was correct that there are multiple design possibilities, it would make no
difference whether the corresponding claim element was revealed in a background description of
the relevant portions of Bracco’s patent or in the portion of the brief explaining that those
elements are not present in JDI’s products.
Counsel’s argument also runs headlong into another, more fundamental problem: if the
ALJ sought to disclose portions of the brief that merely “recite[]” a patent claim on the grounds
that the Bracco claim elements are “public information,” he would have ordered the claim
elements associated with Version 3.1 disclosed as well. But, as discussed, the ALJ and the
Commission agreed that those claim elements should remain redacted. In sum, no matter which
way the Commission tries to cut it, the proposed redactions are inconsistent. And because the
redactions are “internally inconsistent,” they are “arbitrary and capricious.” ANR Storage Co. v.
FERC, 904 F.3d 1020, 1028 (D.C. Cir. 2018).
Counsel for the Commission, though, offered a further response at oral argument.
According to the Commission, JDI forfeited an argument based on inconsistency because it
“didn’t argue it before the Commission” and, instead, raised it “for the first time in their reply
brief” before this Court. June 21, 2019 Hrg. Tr. (Rough at 37:1–7). The Court is unpersuaded.
To be sure, “[i]t is a hard and fast rule of administrative law, rooted in simple fairness, that issues
not raised before an agency are waived and will not be considered by a court on review.”
Nuclear Energy Inst., Inc. v. EPA, 373 F.3d 1251, 1297 (D.C. Cir. 2004) (citing United States v.
L.A. Tucker Truck Lines, Inc., 344 U.S. 33, 37 (1952)). Here, however, the Court concludes that
JDI raised the dispositive issue below and, accordingly, did not forfeit the argument.
Several pages of JDI’s brief seeking confidential treatment highlighted, in large boxes,
inconsistencies in the Commission’s approach. Pointing to these portions, JDI argued that “there
12 is no real difference between the redacted passages reproduced below that the [s]taff seeks to
reclassify. . . and those it has approved.” Dkt. 4-2 at 12 (Confidential Ex. B). JDI identified
specific inconsistencies similar to those raised here. Id. at 12–13. The fact that JDI did not
couch this argument in the register of “arbitrary and capricious” agency action, moreover, is
hardly surprising: JDI was urging the Commission to expand its view of what should be
redacted, not arguing that the agency action must be set aside. In any event, even if JDI did not
raise the argument as clearly as it could have, the Commission was on reasonable notice that its
proposed redactions needed to clear the bar of internal consistency. In short, this was hardly a
case in which the aggrieved party “with[held] legal arguments for tactical reasons,” USAir, Inc.
v. Dep’t of Transp., 969 F.2d 1256, 1260 (D.C. Cir. 1992), or subjected the Commission to
“[u]nfair surprise,” Okla. Dep’t of Envtl. Quality v. EPA, 740 F.3d 185, 192 (D.C. Cir. 2014).
Counsel for the Commission raised one final, fallback argument at oral argument: that
even if the Court found the redactions inconsistent or incoherent, those discrepancies constituted
“harmless error.” June 21, 2019 Hrg. Tr. (Rough at 35:18–36:2). According to counsel for the
Commission, any inconsistencies are simply the result of the Commission having been overly
cautious in its earlier redactions, and, if the Court remands to the Commission, staff will simply
recommend disclosing any portion of JDI’s brief that does not comport with the ALJ’s
reasoning. As an initial matter, the Court is—at this preliminary stage—merely evaluating
whether to preserve the status quo, and any substantive discussion of remand or vacatur is
premature. But, in any event, neither counsel nor the Court knows what the Commission will do
on remand. It is far from clear, for example, that the Commission will not simply expand—
rather than roll back—its existing redactions. The Court is mindful of its limited role and must
not “substitute its judgment for that of the agency.” State Farm, 463 U.S. at 43. In the event that
13 the Court ultimately sets aside the Notice, it would be for the Commission to correct the Notice
in the first instance.
The bottom line is this: because the specific redactions proposed by the Commission are
internally inconsistent and run counter to the reasons given by the agency, JDI appears likely to
succeed on the merits of at least one of its APA claims. At this stage of the litigation, nothing
more is required to tip the first factor in JDI’s favor.
B. Irreparable Harm
Next, the Court must consider whether JDI “is likely to suffer irreparable harm in the
absence of preliminary relief.” Winter, 555 U.S. at 20. “[A] showing that irreparable injury is
‘likely’ is the sine qua non for obtaining a preliminary injunction—it is what justifies the
extraordinary remedy of granting relief before the parties have had the opportunity fully to
develop the evidence and fully to present their respective cases.” Achagzai v. Broad. Bd. of
Governors, No. 14-cv-768, 2016 WL 471274, at *3 (D.D.C. Feb. 8, 2016); see also Chaplaincy
of Full Gospel Churches v. England, 454 F.3d 290, 297 (D.C. Cir. 2006) (“A movant’s failure to
show any irreparable harm is therefore grounds for refusing to issue a preliminary injunction,
even if the other three factors entering the calculus merit such relief.”); Tex. Children’s Hosp. v.
Burwell, 76 F. Supp. 3d 224, 241–42 (D.D.C. 2014); Trudeau v. FTC, 384 F. Supp. 2d 281, 296
(D.D.C. 2005), aff’d, 456 F.3d 178 (D.C. Cir. 2006). As a result, if JDI fails to demonstrate that
it is likely to suffer an irreparable injury, the Court must deny the motion.
JDI contends that this factor “present[s] an easy question” and that it will suffer
irreparable harm “in two distinct senses.” Dkt. 3-1 at 17. First, if JDI’s confidential business
information is disclosed, “[t]here is no way that this Court or any other could compensate JDI for
the potentially enormous competitive harm in disclosure of trade-secret information,” as Bracco
14 could likely use the information to prepare patent claims that would exclude JDI from the market
altogether. Id. Second, JDI argues that disclosure would “defeat[] JDI’s ability to obtain
[judicial] review and keep trade secrets, secret,” because, “[o]nce the ‘cat is out of the bag,’ the
right against disclosure cannot later be vindicated.” Id. at 18 (quoting SEC v. Rajaratnam, 622
F.3d 159, 170 (2d Cir. 2010)). The Commission, on the other hand, contends that JDI will suffer
no injury at all, arguing that “[t]here is simply no cognizable harm from the disclosure of public
patent claim language and public infringement contentions in this case or any other.” Dkt. 12 at
25. That is so, it argues, because “the harm that JDI identifies—that Bracco could use the
redacted information to amend its patent applications to include JDI’s designs—is not only
speculative, but also amounts to nothing more than legitimate and permissible competitive
behavior by Bracco.” Id. at 24–25. Quoting the Federal Circuit, the Commission posits that
“there is nothing improper, illegal or inequitable in filing a patent application for the purpose of
obtaining a right to exclude a known competitor’s product from the market.” Id. at 25 (quoting
Kingsdown Med. Consultants, Ltd. v. Hollister Inc., 863 F.2d 867, 874 (Fed. Cir. 1988)).
The problem with the Commission’s argument is that the Commission has already
conceded its core premise. If “[t]here is . . . no cognizable harm from the disclosure of public
patent claim language and public infringement contentions in this case or any other,” Dkt. 12 at
25, then none of the redactions in JDI’s brief would satisfy the Commission’s two-part test for
confidential treatment. But, of course, the Commission concluded that, where disclosure of
public patent claim elements would reveal JDI’s design choices, that disclosure qualifies as
competitive harm. The ALJ, in other words, has already determined that where a “[specific]
limitation necessarily reveals . . . the [RUBY] elements in question[,] . . . that is competitive
information not available to the public” and is properly withheld as confidential business
15 information. Dkt. 4-3 at 5 (Confidential Ex. C). As described in the prior section, the
Commission has given the green light to numerous redactions. Even if the Commission now
contends that those redactions were unnecessary, the ALJ clearly took the position that—with
both Versions 3.1 and 4—“public infringement contentions” can, and did, constitute “cognizable
harm.” That position, moreover, was a sensible one. To be sure, there is nothing wrong with
Bracco using JDI’s design to seek a continuation patent that it could then use to exclude JDI
from the market; but there is also nothing improper about JDI endeavoring to keep its design
secret.
As the Commission has conceded that disclosure would, in fact, cause injury to JDI, the
Court has little trouble concluding that the injury would be irreparable. In short, “once . . .
putatively protected material is disclosed, the very right sought to be protected has been
destroyed,” In re Sealed Case No. 98-3077, 151 F.3d 1059, 1065 (D.C. Cir. 1998) (quoting In re
Ford Motor Co., 110 F.3d 954, 963 (3d Cir. 1997))—that is, “once disclosed, [it] loses its
confidential nature,” Hosp. Staffing Sols., LLC v. Reyes, 736 F. Supp. 2d 192, 200 (D.D.C.
2010). The Court, accordingly, concludes that JDI has demonstrated that it “is likely to suffer
irreparable harm in the absence of preliminary relief.” Winter, 555 U.S. at 20.
C. Balance of Equities and Public Interest
Finally, JDI must show “that the balance of equities tips in [its] favor, and that an
injunction is in the public interest.” Winter, 555 U.S. at 20. “The[se] last two factors ‘merge
when the Government is the opposing party.’” Guedes, 920 F.3d at 10 (internal citation omitted).
The Commission argues that the balance of equities tips in its favor because “JDI on its own
initiated the inquiry and adjudication of non-infringement with respect to its Version 3.1 and
Version 4 products—products which had not been accused of infringement by Bracco,” and
16 because “JDI had the opportunity to maintain a shroud of secrecy over its products, essentially
by not seeking declaratory judgment as to them.” Dkt. 12 at 25–26. The Commission further
argues that the public interest weighs against an injunction because JDI “should not be permitted
to shield publicly available information and bare legal contentions from the public by simply
alleging that competitive harm may result.” Id. at 26. JDI counters that it “had no expectation”
that it would be forced to disclose confidential information, Dkt. 13 at 15, and further argues that
“[t]he potential harm of a wrong decision against JDI would be substantial” and “denying relief
would extinguish JDI’s right to judicial review,” whereas “the potential harm of a wrong
decision against the Commission would be virtually non-existent,” Dkt. 3-1 at 19.
The Court concludes that, on balance, the third and fourth factors tip in JDI’s favor. “The
primary ‘purpose of a preliminary injunction is to preserve the object of the controversy in its
then existing condition—to preserve the status quo.’” Aamer v. Obama, 742 F.3d 1023, 1043
(D.C. Cir. 2014) (quoting Doeskin Products, Inc. v. United Paper Co., 195 F.2d 356, 358 (7th
Cir. 1952)). Here, issuance of a preliminary injunction accomplishes this purpose with relatively
little harm to the Commission or to the public interest. In the event that the Commission
ultimately prevails, JDI will be required to disclose the redacted material in short order.
Nor is this a case in which JDI will unduly or unjustly profit from keeping this
information temporarily confidential. It is undisputed that JDI’s new designs do not, in fact,
infringe upon Bracco’s existing patents. Although the balance might shift if continued
confidentiality allowed JDI to evade Bracco’s attempts to enforce its existing property rights,
that is not the case. Bracco—who is not a party to this proceeding—has merely lost an
opportunity to use the ongoing Commission proceedings to learn how JDI has redesigned its
products so that Bracco can then seek new patents to, if possible, enjoin the new designs. Bracco
17 has the right to file continuation applications but does not have a statutory or regulatory right to
use the Commission proceedings to gain the information it needs to file the new applications.
The Court further concludes that the public interest would be not be harmed by
preserving JDI’s current redactions. Although there is a “strong presumption in favor of public
access to judicial proceedings,” Johnson v. Greater Se. Cmty. Hosp. Corp., 951 F.2d 1268, 1277
(D.C. Cir. 1991), the adjudication at issue occurs not in an Article III courthouse, but in an
administrative proceeding where confidential information is often protected from public
disclosure. There is, moreover, a strong “public interest” in “protecting confidential business
information and trade secrets.” Council on Am.-Islamic Relations v. Gaubatz, 667 F. Supp. 2d
67, 80 (D.D.C. 2009). The Court also notes that much of the underlying record will remain
sealed regardless of whether the Commission is successful in this action. The parties agree that
the Version 3.1 claims should stay redacted, and JDI represents that the Commission has sealed,
in its entirety, the underlying ALJ decision granting JDI’s motion for summary determination.
See Dkt. 13 at 15. Any public interest served by the marginally increased access to additional
portions of the briefing, accordingly, does not outweigh the public interest in the protection of
JDI’s confidential business information.
* * *
All four factors, accordingly, weigh in favor of issuance of a preliminary injunction.
18 CONCLUSION
For the reasons stated above, it is hereby ORDERED that Plaintiff’s motion for
preliminary injunction, Dkt. 3, and motion to seal, Dkt. 4, are both GRANTED. The
Commission is enjoined from disclosing any portion of JDI’s motion for summary determination
pending further order of the Court. The parties shall appear for a status conference on July 25,
2019 at 3:00 p.m. in Courtroom 21.
SO ORDERED.
/s/ Randolph D. Moss RANDOLPH D. MOSS United States District Judge
Date: July 10, 2019